Kelly Anderson PhD, MPP
Assistant Professor; Director, Pharmaceutical Outcomes Research PhD Program
- Department of Clinical Pharmacy
- Skaggs School of Pharmacy and Pharmaceutical Sciences
Kelly E. Anderson is an Assistant Professor at the University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences and serves as the director of the PhD program in Pharmaceutical Outcomes Research. Dr. Anderson employs econometric and descriptive methods to answer questions about the financing and delivery of care in the Medicare program. Her current research focuses on payment for Medicare Part B drugs, differences in the cost and quality of care between traditional Medicare and Medicare Advantage, and the regulation of Medicare Advantage provider and pharmacy networks. She received a PhD in Health Policy and Management from the Johns Hopkins Bloomberg School of Public Health, as well as Master of Public Policy and Bachelor of Science in Biomedical Engineering degrees from the University of Virginia. Dr. Anderson has also consulted for federal health care agencies, state legislatures, and private companies regarding insurance design and payment policy. She regularly meets with federal and state policymakers to connect the findings from her research to ongoing legislative and regulatory efforts.
Education, Licensure & Certifications
- PhD in Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, 2021
- MPP, University of Virginia Batten School of Leadership and Public Policy, 2013
- BS in Biomedical Engineering, University of Virginia School of Engineering and Applied Sciences, 2012
Affiliations
- Core Faculty, Center for Pharmaceutical Outcomes Research (CePOR), University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences
- Affiliate Scholar, Hopkins Business of Health Initiative (HBHI), Johns Hopkins University
- Faculty Associate, Johns Hopkins Bloomberg School of Public Health, Department of Health Policy and Management